Brand Name: Kryxana
Active Ingredient: Ribociclib
Manufacturer Company Name: Novartis AG
Strength : 200 mg
Supplied as: Pack of 21 tablets
Route of Administration : Oral
A Medication that has cost breast cancer sufferers more than $100,000 a year will be available to patient between $500.00 and $525.00 per pack at Drugssquare.com. Millions of patients with inoperable or metastatic HR-Positive/HER2-Negative breast cancer will benefit from the listing of Ribociclib (Kryxana).
Ribociclib Kryxana tablet is used in combination with an aromatase inhibitor (AI) for the treatment of perimenopausal women with hormone receptor–positive, HER2-negative advanced or metastatic breast cancer.
“In clinical trials, Ribociclib Kryxana have made a huge difference to women’s lives – slowing down tumour growth for nearly a year, and delaying the need for chemotherapy with all its potentially debilitating side-effects. These drugs have allowed women to live a normal life for longer.”
Place your order online or send your enquiry at email@example.com to buy KYRXANA tablet :
In South East Asia – China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
In North America – United States of America (USA).
In South America – Peru, Venezuela.
In Europe – Romania, Switzerland, Georgia, Italy, UK, Ukraine, Azerbhaijan, Latvia.
In Russia – Moldova, Uzbekistan, Mongolia.
In United Arab Emirates – Iran, Saudi Arabia, Jordan.
In African Countries – Zimbabwe.
In Australia and New Zealand.
Interested to Know More ? Read Our Blog – https://bit.ly/2OQ5b4d